During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.Below are the ratings of the most accurate analysts for three high-yield ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Financial Performance - Net sales for Q3 2025 were $699 million, a decrease of 13% from $804 million in Q3 2024, primarily due to lower sales volumes and average selling prices of TiO2 [119]. - TiO2 revenue decreased by 11% or $66 million compared to the prior year quarter, driven by a $47 million decrease in sales volumes and a $29 million decrease in average selling prices [119]. - Zircon revenue decreased by 20% from Q3 2024 to Q3 2025, primarily due to a 16% decline in average selling prices and a 4% decrease in sales volumes [115]. - Gross profit for Q3 2025 was $52 million, representing a gross margin of 7.4%, down from 15.9% in the prior year [118]. - The company reported a net loss of $100 million for Q3 2025, compared to a net loss of $25 million in Q3 2024, reflecting a significant increase in restructuring charges [118]. - Adjusted EBITDA for Q3 2025 was $74 million, down from $143 million in Q3 2024, with adjusted EBITDA as a percentage of net sales decreasing to 10.6% from 17.8% [118]. - For the nine months ended September 30, 2025, net sales were $2,168 million, a decrease of 10% compared to $2,398 million for the same period in 2024 [128]. - For the nine months ended September 30, 2025, total net sales decreased by 10% to $2,168 million compared to $2,398 million in the prior year [129]. - TiO2 revenue decreased by 8% or $153 million, primarily due to a $126 million decrease in sales volumes and a $41 million decrease in average selling prices [129]. - Gross margin for the nine months ended September 30, 2025 was $230 million, representing 10.6% of net sales, down from 16.6% in the prior year [129]. - Loss from operations was $139 million for the nine months ended September 30, 2025, a decrease of $310 million compared to income from operations of $171 million in the prior year [131]. - Adjusted EBITDA as a percentage of net sales was 12.9% for the nine months ended September 30, 2025, a decrease of 5.2 points from 18.1% in the prior year [137]. - The company reported a net loss of $296 million for the nine months ended September 30, 2025, compared to a net loss of $24 million for the same period in 2024, representing an increase in net loss of $272 million year-over-year [162]. Liquidity and Debt - Total available liquidity as of September 30, 2025, was $664 million, including $185 million in cash and cash equivalents [116]. - Total debt as of September 30, 2025, was $3.2 billion, with a net debt to trailing twelve months adjusted EBITDA ratio of 7.5x [116]. - Cash and cash equivalents increased to $185 million as of September 30, 2025, up from $151 million at December 31, 2024 [140]. - Working capital was $1.5 billion at September 30, 2025, compared to $1.3 billion at December 31, 2024 [141]. - Short-term and long-term debt increased to $3.2 billion as of September 30, 2025, compared to $2.9 billion at December 31, 2024 [155]. - The company’s long-term debt, net, increased to $3,136 million as of September 30, 2025, up from $2,759 million as of December 31, 2024 [172]. - The company’s net debt to trailing twelve months Adjusted EBITDA ratio increased to 7.5x as of September 30, 2025, compared to 4.8x as of December 31, 2024 [172]. - The company issued $400 million of 9.125% senior secured notes due 2030 on September 26, 2025 [153]. Cash Flow - Cash used in operating activities was $61 million for the nine months ended September 30, 2025, a decrease from cash provided by operating activities of $218 million in the prior year, primarily due to a decrease in income-related cash generation [162]. - Net cash used in investing activities increased to $255 million in the nine months ended September 30, 2025, compared to $226 million in the same period of 2024, driven by higher capital expenditures of $273 million [163]. - The company generated net cash provided by financing activities of $345 million for the nine months ended September 30, 2025, compared to cash used in financing activities of $97 million in the prior year, primarily from net proceeds of long-term debt of $379 million [164]. Restructuring and Charges - Restructuring and other charges for Q3 2025 amounted to $25 million, primarily related to the idling of the Botlek plant [119]. - The company incurred restructuring and other charges of $25 million for the three months ended September 30, 2025, and $150 million for the nine months ended September 30, 2025 [183]. - Interest expense for the three months ended September 30, 2025, was $48 million, with a total of $176 million for the trailing twelve months [178]. Environmental and Compliance Costs - The company is subject to significant environmental compliance costs, which are expected to continue to be substantial in the foreseeable future [188]. Currency Risk and Hedging - The company is exposed to currency risk primarily in South Africa and Australia, where revenues are earned in U.S. dollars while expenses are incurred in local currencies [200]. - The company enters into foreign currency contracts to hedge forecasted non-functional currency sales and costs for its subsidiaries in South Africa and Australia [201]. - As of September 30, 2025, the company had notional amounts of 136 million Australian dollars (approximately $90 million) in foreign currency contracts to hedge against fluctuations in currency rates for its Australian subsidiaries' cost of sales [201]. - The company had notional amounts of 975 million South African Rand (approximately $56 million) to reduce exposure of its South African subsidiaries' third-party sales to currency fluctuations [201]. - As of September 30, 2025, the company had outstanding foreign currency contracts totaling 470 million South African Rand (approximately $27 million) and 161 million Australian dollars (approximately $106 million) [202]. - The company utilized a combination of zero-cost collars, put options, and forward contracts to manage currency exposure, designating these as cash flow hedges [201]. - As of September 30, 2025, the company had notional amounts of 61 million Pound Sterling (approximately $82 million) and 40 million Euro (approximately $47 million) in outstanding foreign currency contracts [202]. - A hypothetical 1% increase in interest rates would result in a net decrease to pre-tax income of approximately $7 million on an annualized basis [193]. - The company recorded a net unrealized gain of $1 million related to interest rate swaps as of September 30, 2025 [198]. - The company recorded a net unrealized gain of $6 million recorded in "Accumulated other comprehensive loss" on the balance sheet, expected to be fully recognized in earnings over the next twelve months [201]. - The company recorded a net loss of $14 million in "Accumulated other comprehensive loss" at December 31, 2024 [201].

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $699 million, a decrease of 13% year-over-year, driven by lower sales volumes and unfavorable pricing for TiO2 and zircon [8][9] - Loss from operations was $43 million, with a net loss attributable to Tronox of $99 million, including $27 million in restructuring charges [8][9] - Adjusted EBITDA was $74 million, representing a 48% decline year-on-year, with an adjusted EBITDA margin of 10.6% [8][11] - Free cash flow was a use of $137 million, including $80 million in capital expenditures [8][9] Business Line Data and Key Metrics Changes - TiO2 revenues decreased by 11% year-over-year, driven by an 8% decrease in volumes and a 5% decline in average selling prices [9][10] - Zircon revenues decreased by 20% compared to the prior year, due to a 16% decrease in price and a 4% decline in volumes [10] - Revenue from other products decreased by 21% year-over-year, but increased by 18% sequentially due to higher sales of pig iron and heavy mineral concentrate tailings [10] Market Data and Key Metrics Changes - The zircon market faced unexpected headwinds, particularly in China, where both pricing and volumes continued to decline [3][4] - Europe, the Middle East, and North America experienced sharper seasonal declines amid market weakness and competitive pressures [9] - Latin America saw typical seasonal uplift, although weaker than expected, while Asia-Pacific growth was muted by competition and a temporary stay on India anti-dumping duties [10] Company Strategy and Development Direction - The company is focused on cost improvement programs, targeting over $60 million in annualized savings by the end of 2025 and $125-$175 million by the end of 2026 [4][20] - Tronox is reinforcing its operational foundation and cash flow management through temporary idling of certain plants and adjusting production rates [4][21] - The company is also advancing its rare earth strategy, with mining operations in Australia and South Africa containing substantial amounts of monazite [7][18] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing challenges from weaker demand, downstream destocking, and heightened competition, but expressed optimism about future sales volumes due to competitors' insolvency proceedings [3][4] - The company expects Q4 2025 revenue and adjusted EBITDA to be relatively flat compared to Q3, driven by weaker pricing but improving volumes [19][20] - Management remains confident in the ability to navigate the current downturn and deliver long-term shareholder value [23] Other Important Information - The company raised $400 million in senior secured notes to enhance liquidity and repay borrowings [5][12] - Liquidity as of September 30 was $664 million, with $185 million in cash and cash equivalents [12][13] - The company returned $20 million to shareholders in the form of dividends in Q3 [14] Q&A Session Summary Question: Impact of anti-dumping measures and market size - Management acknowledged that the Brazil and Saudi Arabia markets are lower than India, but expressed confidence that India's duties will be reinstated soon, which would stabilize volumes [25][27] Question: Rare earths opportunity and refining capabilities - Management confirmed ongoing mining of monazite in Australia and South Africa, with plans for further development in refining and separation through partnerships [30][32] Question: Duration of idling plants and potential permanence - The Fuzhou plant is idled to preserve cash, with decisions on its future dependent on market conditions, while Stallingborough is expected to return to full rates in Q4 [37][39] Question: 2026 earnings potential and cost savings impact - Management indicated that the Sustainable Cost Improvement Program is expected to yield significant savings in 2026, with a focus on operational efficiencies [40][42] Question: Destocking and inventory rebuilding expectations - Management noted that destocking occurred earlier than expected, but anticipated a return to normal buying patterns in Q4, indicating a potential recovery [51][53]

Financial Performance - Revenue decreased by 13% year-over-year, from $804 million in Q3 2024 to $699 million in Q3 2025[11, 16] - Adjusted EBITDA decreased by 48% year-over-year, from $143 million in Q3 2024 to $74 million in Q3 2025[11, 25] - Adjusted EBITDA margin decreased by 720 basis points year-over-year, from 17.8% in Q3 2024 to 10.6% in Q3 2025[11, 25] - Free cash flow was a use of $137 million in Q3 2025, compared to a use of $14 million in Q3 2024[11] - Net loss attributable to Tronox was $99 million in Q3 2025, compared to a net loss of $25 million in Q3 2024[11, 13] Operational Highlights - TiO2 volumes decreased by 8% year-over-year and 4% quarter-over-quarter[16, 21] - Zircon volumes decreased by 4% year-over-year and 7% quarter-over-quarter[16, 21] - The company is on track to deliver sustainable run-rate cost improvements of more than $60 million in 2025 and $125-$175 million by the end of 2026[10] Liquidity and Capital Allocation - The company raised $400 million of secured notes in Q3 2025[10, 33] - Total debt was $3.2 billion as of September 30, 2025, with a net leverage ratio of 7.5x on a trailing twelve-month basis[33] - Total available liquidity was $664 million as of September 30, 2025, including $185 million in cash and cash equivalents[33]

Financial Performance - Revenue for Q3 2025 was $699 million, a 13% decrease year-over-year and a 4% decrease quarter-over-quarter[3]. - Net loss attributable to Tronox was $99 million, or a loss of $0.63 per diluted share, compared to a net loss of $25 million, or a loss of $0.16 per diluted share in Q3 2024[12]. - Adjusted EBITDA was $74 million, representing a 48% decrease year-over-year, with an adjusted EBITDA margin of 10.6%[13]. - Net sales for Q3 2025 were $699 million, a decrease of 13.1% compared to $804 million in Q3 2024[28]. - Gross profit for Q3 2025 was $52 million, down from $128 million in Q3 2024, reflecting a gross margin of 7.4% compared to 15.9%[28]. - Adjusted net loss attributable to Tronox Holdings plc for Q3 2025 was $72 million, compared to $21 million in Q3 2024[29]. - Net loss for the nine months ended September 30, 2025, was $296 million, compared to a net loss of $24 million for the same period in 2024[36]. - Adjusted EBITDA for the nine months ended September 30, 2025, was $279 million, down from $435 million in 2024, representing a decrease of approximately 36%[37]. - Net sales for the three months ended September 30, 2025, were $699 million, compared to $804 million in 2024, reflecting a decline of about 13%[37]. - Adjusted EBITDA as a percentage of net sales for the three months ended September 30, 2025, was 10.6%, down from 17.8% in 2024[37]. Revenue Breakdown - TiO2 revenue was $550 million, down 11% year-over-year, driven by an 8% decline in volumes and a 5% decline in average selling prices[9]. - Zircon revenue decreased 20% to $59 million, impacted by a 16% decrease in average selling prices and a 4% decline in sales volumes[10]. Cash Flow and Liquidity - Free cash flow for Q3 2025 was a use of $137 million, with expectations for positive free cash flow in Q4 2025 and 2026[17][19]. - Free cash flow for the nine months ended September 30, 2025, was $(334) million, compared to $(197) million for the six months ended June 30, 2025[43]. - Cash provided by financing activities for the nine months ended September 30, 2025, was $345 million, contrasting with cash used in financing activities of $(97) million in 2024[36]. - Tronox raised $400 million in senior secured notes, increasing available liquidity to $664 million[16]. Capital Expenditures - Capital expenditures for the quarter were $80 million, focusing on key capital projects to sustain vertical integration[17]. - Capital expenditures for Q3 2025 were $80 million, down from $101 million in Q3 2024[28]. - Capital expenditures for the nine months ended September 30, 2025, were $273 million, compared to $253 million in 2024[36]. Debt and Assets - Long-term debt increased to $3,136 million as of September 30, 2025, compared to $2,759 million at the end of 2024[34]. - Total assets as of September 30, 2025, were $6,303 million, an increase from $6,038 million as of December 31, 2024[34]. - Net debt to trailing-twelve month Adjusted EBITDA ratio increased to 7.5x as of September 30, 2025, compared to 4.8x at the end of 2024[37]. Strategic Initiatives - The company is advancing its rare earth strategy, taking a 5% equity interest in Lion Rock Minerals to support resource development[18]. - The company reported a restructuring charge of $153 million for the nine months ended September 30, 2025, with no such charges reported in 2024[36]. - Tronox Holdings plc's restructuring and other charges amounted to $25 million in Q3 2025, with no such charges reported in Q3 2024[28].

Financial Performance - Tronox reported a quarterly loss of $0.46 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.21, and compared to a loss of $0.13 per share a year ago, indicating a significant earnings surprise of -119.05% [1] - The company posted revenues of $699 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 5.28%, and down from $804 million in the same quarter last year [2] - Over the last four quarters, Tronox has not surpassed consensus EPS estimates and has consistently missed revenue estimates [2] Stock Performance - Tronox shares have declined approximately 68.3% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The current Zacks Rank for Tronox is 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.11 on revenues of $729.64 million, and for the current fiscal year, it is -$0.75 on revenues of $2.94 billion [7] - The trend of estimate revisions for Tronox was unfavorable prior to the earnings release, which may impact future stock movements [6] Industry Context - The Chemical - Diversified industry, to which Tronox belongs, is currently ranked in the bottom 8% of over 250 Zacks industries, suggesting a challenging environment for stocks in this sector [8] - Comparatively, Chemours, another company in the same industry, is expected to report a quarterly earnings decline of 40% year-over-year, with revenues projected at $1.49 billion, down 0.6% from the previous year [9][10]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Accessibility StatementSkip Navigation STAMFORD, Conn., Nov. 5, 2025 /PRNewswire/ -- Tronox Holdings plc (NYSE:TROX) ("Tronox" or the "Company"), the world's leading integrated manufacturer of titanium dioxide ("TiO2 ") pigment, today reported its financial results for the quarter ending September 30, 2025, as follows: Third Quarter 2025 Financial Highlights: Updated Outlook: This outlook is based on Tronox's views on current global economic activity and is subject to changes and impacts associated with th ...

Core Viewpoint - Tronox Holdings plc is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 12, 2025, and July 30, 2025 [1][2] Company Performance - The lawsuit claims that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and forecasting processes, which ultimately led to declining sales and increased costs [2] - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales for the second quarter of fiscal 2025, attributing the decline to a softer coatings season and heightened competition [2] - Following the announcement, Tronox revised its 2025 financial outlook, lowering full-year revenue guidance and reducing its dividend by 60% [2] - The stock price of Tronox plummeted from $5.14 per share on July 30, 2025, to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in one day [2] Legal Proceedings - Investors who suffered losses during the specified timeframe have until November 3, 2025, to request appointment as lead plaintiff in the class action [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3] Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]